Chaperot L - Search Results

1

A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Ceribelli M, Hou ZE, Kelly PN, Huang DW, Wright G, Ganapathi K, Evbuomwan MO, Pittaluga S, Shaffer AL, Marcucci G, Forman SJ, Xiao W, Guha R, Zhang X, Ferrer M, Chaperot L, Plumas J, Jaffe ES, Thomas CJ, Reizis B, Staudt LM. Ceribelli M, et al. Among authors: chaperot l. Cancer Cell. 2016 Nov 14;30(5):764-778. doi: 10.1016/j.ccell.2016.10.002. Cancer Cell. 2016. PMID: 27846392 Free PMC article.

2

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

Manches O, Lui G, Chaperot L, Gressin R, Molens JP, Jacob MC, Sotto JJ, Leroux D, Bensa JC, Plumas J. Manches O, et al. Among authors: chaperot l. Blood. 2003 Feb 1;101(3):949-54. doi: 10.1182/blood-2002-02-0469. Epub 2002 Oct 3. Blood. 2003. PMID: 12393572 Free article.

3

Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas.

Chaperot L, Manches O, Mi JQ, Moine A, Jacob MC, Gressin R, Molens JP, Sotto JJ, Leroux D, Bensa JC, Plumas J. Chaperot L, et al. Br J Haematol. 2002 Nov;119(2):425-31. doi: 10.1046/j.1365-2141.2002.03885.x. Br J Haematol. 2002. PMID: 12406081 Free article.

4

Origin and filiation of human plasmacytoid dendritic cells.

Brière F, Bendriss-Vermare N, Delale T, Burg S, Corbet C, Rissoan MC, Chaperot L, Plumas J, Jacob MC, Trinchieri G, Bates EE. Brière F, et al. Among authors: chaperot l. Hum Immunol. 2002 Dec;63(12):1081-93. doi: 10.1016/s0198-8859(02)00746-2. Hum Immunol. 2002. PMID: 12480251 Review.

5

CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.

Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Béné MC, Bensa JC, Brière F, Plumas J. Jacob MC, et al. Among authors: chaperot l. Haematologica. 2003 Aug;88(8):941-55. Haematologica. 2003. PMID: 12935983

6

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts.

Chaperot L, Perrot I, Jacob MC, Blanchard D, Salaun V, Deneys V, Lebecque S, Brière F, Bensa JC, Plumas J. Chaperot L, et al. Eur J Immunol. 2004 Feb;34(2):418-26. doi: 10.1002/eji.200324531. Eur J Immunol. 2004. PMID: 14768046 Free article.

7

Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.

Manches O, Plumas J, Lui G, Chaperot L, Molens JP, Sotto JJ, Bensa JC, Galili U. Manches O, et al. Among authors: chaperot l. Haematologica. 2005 May;90(5):625-34. Haematologica. 2005. PMID: 15921377

8

Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.

Chaperot L, Blum A, Manches O, Lui G, Angel J, Molens JP, Plumas J. Chaperot L, et al. J Immunol. 2006 Jan 1;176(1):248-55. doi: 10.4049/jimmunol.176.1.248. J Immunol. 2006. PMID: 16365416

9

Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells.

Blum A, Chaperot L, Molens JP, Foissaud V, Plantaz D, Plumas J. Blum A, et al. Among authors: chaperot l. Exp Hematol. 2006 Dec;34(12):1655-62. doi: 10.1016/j.exphem.2006.08.002. Exp Hematol. 2006. PMID: 17157162 Free article.

10

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells.

Angel J, Chaperot L, Molens JP, Mezin P, Amacker M, Zurbriggen R, Grichine A, Plumas J. Angel J, et al. Among authors: chaperot l. Vaccine. 2007 May 10;25(19):3913-21. doi: 10.1016/j.vaccine.2007.01.101. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17336432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters